Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients.
about
Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Polymorphisms in the promoter ...... in multiple myeloma patients.
@en
Polymorphisms in the promoter ...... in multiple myeloma patients.
@nl
type
label
Polymorphisms in the promoter ...... in multiple myeloma patients.
@en
Polymorphisms in the promoter ...... in multiple myeloma patients.
@nl
prefLabel
Polymorphisms in the promoter ...... in multiple myeloma patients.
@en
Polymorphisms in the promoter ...... in multiple myeloma patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
Polymorphisms in the promoter ...... y in multiple myeloma patients
@en
P2093
Adam Nogalski
Aneta Szudy-Szczyrek
Jacek Sompor
Michał Szczyrek
P2860
P304
24054-24068
P356
10.18632/ONCOTARGET.25307
P407
P577
2018-05-08T00:00:00Z